Aligos Therapeutics Inc (ALGS) Directors and Executive Officers

Officers & Directors

- Lesley Ann Calhoun: Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer)
- Bridget Martell: Director
- Jack B. Nielsen: Director
- Lawrence M. Blatt, Ph.D.: President, Chairman, and Chief Executive Officer (Principal Executive Officer)
- K. Peter Hirth: Director
- James Scopa: Director
- Carole Nuechterlein: Director ,

Aligos Therapeutics Inc currently has 82 employees.

News about Aligos Therapeutics Inc Key Personnel

Aligos Therapeutics Strengthens Leadership and Reports Breakthrough Advances in MASH Treatment Amidst Market Challenges

In a significant strategic move reflecting its commitment to advancing therapeutic interventions for liver diseases, Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical-stage biopharmaceutical company based in South San Francisco, has appointed David Perry as Vice President of Business Development, effective immediately. Perry’s extensive background in the biopharmaceutical sector, combined with his keen insight into market dynamics, positions him to play a crucial role in navigating the evolving landscape of therapeutic development and commercial engagement for the company.This appointment comes on the heels of encouraging developments in Aligos’s clinical portfolio, particularly the promising topline ...